New global nephrology solutions are deploying technological advancements encompassing a diverse array of applications, from kidney imaging techniques to remote patient monitoring systems. With enhanced accuracy and efficiency, these technologies empower healthcare professionals to diagnose renal conditions swiftly and accurately, improving patient outcomes.
Real-time data analytics enable timely interventions, ensuring optimal patient management and treatment planning. Renal care providers benefit from streamlined workflows and improved resource allocation, facilitating better patient care delivery. Ultimately, patients reap the rewards of these advancements through enhanced diagnostic accuracy, personalized treatment plans, and improved overall quality of life.
Continue reading to gain up-to-date and data-driven insights on:
- Profiles of 10 Emerging Global Nephrology Solutions
- How to Scout the Best Nephrology Solutions Easily
Click to download
Key Takeaways
Drawing insights from the Big Data & AI-powered StartUs Insights Discovery Platform that provides data on over 4.7+ million emerging companies globally, we explore the evolving landscape of the nephrology industry. This sector is marked by key trends and a substantial workforce, shaping its future. The last time we updated this report was 5 days ago. If there’s something missing or off, your tips are welcome! Here are some key insights at a glance:
- Latest Nephrology Trends: Some of the top trends in the global nephrology industry are remote patient monitoring, AI Diagnostics, precision medicine, and home dialysis devices.
- Nephrology Industry Statistics: The sector comprises 17K+ organizations worldwide. On average, it employs about 112 people in 2K+ new companies founded in the last five years, witnessing 2020 as the average founding year. Moreover, the average funding received by the nephrology industry per round in the same span is USD 31.5 million.
- 10 New Global Nephrology Solutions to Watch:
- EvoMedics – Renal Care Telehealth
- Kiwecare – CKD Management Device
- Nephrolyx – Kidney Function Diagnostics
- Oska Health – Renal Therapy Recommendations
- NuRenal – Renal Risk Assessment
- Curespec – Real Time Renal Function Monitoring
- eMedicals Healthtech – Clinical Decision Support
- Uray – Photonics & AI-based Urinalysis
- HI-Bio – Renal Precision Medicine
- SanReno – Targeted Renal Therapeutics
Meet 10 out of 2K+ New Global Nephrology Solutions
In this section, we highlight 10 emerging nephrology solutions that are leading to innovative healthtech solutions. These companies are rapidly responding to renal concerns and evolving patient demands. By pioneering advanced platforms, new clinical decision support apps, smart sensors, and 3D-printed renal transplants, these companies are setting new standards in the nephrology industry.
Note on Signal Strength
One of the unique metrics we feature for each company is Signal Strength, a proprietary data point generated by our Discovery Platform. It gauges the extent to which a company’s influence has permeated the global ecosystem of startups, scaleups, and emerging companies. This proprietary metric serves as a valuable guidepost for understanding a company’s standing in the broader market landscape.
1. EvoMedics
- Founding Year: 2019
- Employee Range: 2-10
- Location: Denmark
- Signal Strength: Strong
- What they do: EvoMedics develops an AI-powered telehealth platform for renal disease management, focusing on renal replacement therapy and vascular access. The platform offers precision medicine and individualized healthcare by leveraging machine learning algorithms to enhance patient care. It integrates big data to predict hospitalization risks and optimize treatment pathways for chronic kidney disease. It supports clinicians in determining the optimal type of vascular access, modality, and timing for patients. Healthcare providers benefit from the platform’s ability to detect early signs of complications, streamlining patient flow.
2. Kiwecare
- Founding Year: 2019
- Employee Range: 2-10
- Location: Finland
- Signal Strength: Weak
- What they do: Kiwecare develops a device for chronic kidney disease management that enhances the efficiency and effectiveness of peritoneal dialysis. It supports real-time monitoring and adjustment of treatment protocols, ensuring optimal patient outcomes. It integrates seamlessly with existing healthcare systems, facilitating a smoother workflow for medical professionals. Patients with end-stage kidney disease benefit directly from this advanced care approach. The device reduces the overall cost of kidney care by minimizing the need for frequent clinical visits.
3. Nephrolyx
- Founding Year: 2021
- Employee Range: 2-10
- Location: Germany
- Signal Strength: Very Strong
- What they do: Nephrolyx develops a device that measures the glomerular filtration rate (GFR) in clinical settings, enhancing kidney function diagnostics. The company’s Nephrolyx IVDx, integrates existing diagnostics kits with a digital platform for rapid GFR assessment using the Iohexol-Plasma-Clearance method. This approach delivers results within a few hours, allowing for timely adjustments to patient treatment plans. The company provides physicians and medical staff with a comprehensive package that includes kit provisioning, software installation, and training. Nephrolyx IVDx provides cost-effective and quick diagnostic solutions compared to traditional methods.
4. Oska Health
- Founding Year: 2022
- Employee Range: 2-10
- Location: Germany
- Signal Strength: very strong
- What they do: Oska Health offers a digital platform to support individuals with chronic kidney disease. The platform integrates an app, qualified nursing staff, and AI algorithms to optimize medical therapy recommendations for patients. It focuses on early detection and individualized care, reducing complications associated with cardiovascular diseases. Oska Health’s platform includes behavioral changes, correct medication intake, and promoting a healthy lifestyle to improve patient outcomes. Patients with chronic kidney disease benefit from this targeted support, which also reduces hospital stays and treatment costs. The company collaborates with healthcare professionals to enhance the treatment of multi-morbid chronic patients.
5. NuRenal
- Founding Year: 2022
- Employee Range: 2-10
- Location: USA
- Signal Strength: Medium
- What they do: NuRenal develops RenalTrak, a chronic kidney disease management platform, focusing on enhancing patient outcomes. It integrates real-time data monitoring with personalized treatment plans. It utilizes ML algorithms to analyze patient data, enabling proactive adjustments to therapy protocols. RenalTrak supports healthcare providers by offering detailed insights into patient health trends and potential risk factors. Patients benefit directly from this technology, as it allows for more tailored and effective management of their condition. Additionally, the platform facilitates seamless communication between patients and their care teams, ensuring consistent care delivery.
6. Curespec
- Founding Year: 2020
- Employee Range: 2-10
- Location: USA
- Signal Strength: Very Strong
- What they do: CureSpec develops KidneyPro, a kidney care platform that employs AI algorithms to monitor renal function in real-time, offering precise data analysis. This technology supports clinicians in making informed decisions, thereby improving treatment accuracy. Additionally, KidneyPro integrates seamlessly with existing hospital systems, ensuring a smooth workflow for healthcare professionals. Patients with chronic kidney diseases benefit significantly from this approach, as it allows for early intervention and personalized care plans. The platform also facilitates research by providing a rich dataset for studying renal diseases.
7. eMedical Healthtech
- Founding Year: 2020
- Employee Range: 2-10
- Location: Germany
- Signal Strength: Very Strong
- What they do: eMedicals Healthtech develops a digital platform for chronic kidney disease (CKD) management. The company’s primary platform, kidi, integrates various functionalities to support both patients and healthcare providers. It enables CKD patients to manage their diet, medication, and dialysis schedules effectively. For healthcare professionals, kidi provides decision support tools that enhance the quality of therapeutic decisions through advanced analytics and communication features. Health insurers benefit from the platform by experiencing cost reductions due to decreased hospital stays and delayed dialysis onset. Research institutions gain access to valuable real-life data, facilitating the development of innovative treatment methods.
8. Uray
- Founding Year: 2021
- Employee Range: 2-10
- Location: Singapore
- Signal Strength: Medium Strong
- What they do: Uray develops a personal health device that simplifies urine sample analysis using photonics and AI. This device performs a urinalysis of 19 biomarkers, providing real-time health data to users. The device operates without reagents, enhancing the efficiency and accuracy of the tests. Users place a urine sample in the device, which then processes and sends data to a synchronized application via Wi-Fi. The system supports the monitoring of chronic diseases, pregnancy, and sports safety. Individuals with chronic kidney conditions and those monitoring general wellness benefit from this technology.
9. HI-Bio
- Founding Year: 2021
- Employee Range: 11-50
- Location: USA
- Signal Strength: Very Strong
- What they do: HI-Bio develops therapies for immune-mediated diseases by leveraging deep immunological insights and human genetics. The company’s precision medicine approach identifies molecular and cellular signatures of renal diseases, enabling targeted therapeutic development. Felzartamab targets mature plasma cells to drive diseases through autoantibody production. This antibody shows promise for treating primary membranous nephropathy by reducing harmful autoantibodies. Another significant therapy from the company, Izastobart/HIB210, exhibits enhanced activity against neutrophils, crucial in several immune-mediated conditions. Patients suffering from such chronic renal diseases benefit from these advanced therapies.
10. SanReno
- Founding Year: 2021
- Employee Range: 11-50
- Location: China
- Signal Strength: Very Strong
- What they do: SanReno develops innovative therapies for kidney diseases, focusing on addressing unmet medical needs in nephrology. The company offers two significant therapies, Atrasentan and BION-1301, targeting the treatment of Immunoglobulin A Nephropathy (IgAN), a prevalent condition in the Asian population. Atrasentan, a selective endothelin receptor antagonist, undergoes a global phase III study to assess its efficacy in reducing proteinuria in IgAN patients. This therapy slows the annual decline in estimated glomerular filtration rate (eGFR), managing kidney diseases. BION-1301, a monoclonal antibody, demonstrates significant proteinuria reduction and tolerability in phase I/II clinical trials, indicating its potential as a disease-modifying drug for IgAN. Patients suffering from IgAN stand to benefit from these therapies, potentially altering the treatment landscape for this chronic condition.
Quick Tip to Find New Global Nephrology Solutions
Utilizing a SaaS platform like the Discovery Platform for identifying new global nephrology solutions provides significant benefits compared to traditional scouting methods:
- Streamlined Efficiency: The Discovery Platform offers advanced tools that streamline the scouting process. It replaces hours of your conventional desk research, saving time and resources in identifying kidney care innovations.
- Access to Real-time Insights: Gain a competitive edge with up-to-date information on the latest trends in the nephrology industry. The platform keeps you informed with near real-time updates on emerging nephrology solutions and news, enabling you to make swift and informed decisions.
- Tailored Exploration: Customize your search to focus on specific niches within the kidney care sector, such as remote monitoring, precision medicine, or renal transplant. The platform’s diverse filtering options allow you to target your scouting efforts precisely, ensuring that you find the most relevant and groundbreaking companies in the field.
Ready to Explore All New Global Nephrology Solutions?
We’ve explored the dynamic landscape of the nephrology industry, examining the latest trends and spotlighting exceptional companies driving innovation. To dive deeper, download our free Healthcare Report or schedule a demo of the Discovery Platform for a customized exploration of these groundbreaking developments. If you’re an expert in startups or emerging tech, we invite you to contribute to our insights.
